MicroRNA profiles during galectin‑9‑induced apoptosis of pancreatic cancer cells

  • Authors:
    • Ryoichi Okura
    • Shintaro Fujihara
    • Hisakazu Iwama
    • Asahiro Morishita
    • Taiga Chiyo
    • Miwako Watanabe
    • Kayo Hirose
    • Kiyoyuki Kobayashi
    • Takayuki Fujimori
    • Kiyohito Kato
    • Hideki Kamada
    • Hideki Kobara
    • Hirohito Mori
    • Toshiro Niki
    • Mitsuomi Hirashima
    • Keiichi Okano
    • Yasuyuki Suzuki
    • Tsutomu Masaki
  • View Affiliations

  • Published online on: November 1, 2017     https://doi.org/10.3892/ol.2017.7316
  • Pages:407-414
Metrics: HTML 0 views | PDF 0 views
0

Abstract

Pancreatic cancer is the eighth‑leading cause of cancer‑associated mortality in males and the ninth‑leading cause in females worldwide. Even when diagnosed early enough to be potentially resectable, the prognosis of invasive pancreatic cancer is poor. Galectin‑9 (Gal‑9) is a tandem‑repeat type galectin that has recently been demonstrated to possess an anti‑proliferative effect on cancer cells. Therefore, the present study evaluated the effects of Gal‑9 on the proliferation of human pancreatic cancer cells and examined the microRNAs that are associated with the antitumor effects of Gal‑9. Gal‑9 suppressed the proliferation of multiple pancreatic cancer cell lines. In addition, Gal‑9 treatment increased the levels of caspase‑cleaved keratin 18 and the expression of cytochrome c in pancreatic cancer cell lines. This data suggests that Gal‑9 induces intrinsic apoptosis in pancreatic cancer cell lines through the caspase‑dependent and caspase‑independent pathways. In addition, Gal‑9 reduced the expression levels of phosphorylated epidermal growth factor receptor and numerous receptor tyrosine kinases (RTKs). In conclusion, Gal‑9 may suppress the growth of human pancreatic cancer cells in vitro. These findings suggest that Gal‑9 may be a new therapeutic agent for the treatment of pancreatic cancer.

Related Articles

Journal Cover

January 2018
Volume 15 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Okura, R., Fujihara, S., Iwama, H., Morishita, A., Chiyo, T., Watanabe, M. ... Masaki, T. (2018). MicroRNA profiles during galectin‑9‑induced apoptosis of pancreatic cancer cells. Oncology Letters, 15, 407-414. https://doi.org/10.3892/ol.2017.7316
MLA
Okura, R., Fujihara, S., Iwama, H., Morishita, A., Chiyo, T., Watanabe, M., Hirose, K., Kobayashi, K., Fujimori, T., Kato, K., Kamada, H., Kobara, H., Mori, H., Niki, T., Hirashima, M., Okano, K., Suzuki, Y., Masaki, T."MicroRNA profiles during galectin‑9‑induced apoptosis of pancreatic cancer cells". Oncology Letters 15.1 (2018): 407-414.
Chicago
Okura, R., Fujihara, S., Iwama, H., Morishita, A., Chiyo, T., Watanabe, M., Hirose, K., Kobayashi, K., Fujimori, T., Kato, K., Kamada, H., Kobara, H., Mori, H., Niki, T., Hirashima, M., Okano, K., Suzuki, Y., Masaki, T."MicroRNA profiles during galectin‑9‑induced apoptosis of pancreatic cancer cells". Oncology Letters 15, no. 1 (2018): 407-414. https://doi.org/10.3892/ol.2017.7316